Renal Insufficiency, Chronic Clinical Trial
Official title:
Interventional Study Targeting Oral Infections in Patients With Chronic Kidney Disease
Verified date | August 2015 |
Source | University of Copenhagen |
Contact | n/a |
Is FDA regulated | No |
Health authority | Denmark: Danish Dataprotection Agency |
Study type | Interventional |
This study aims to investigate the prevalence of oral infection in chronic renal disease patients and to examine whether a focused oral hygiene intervention can reduce oral infection leading to reduced systemic inflammatory parameters in chronic renal disease patients in hemodialysis, chronic renal disease patients waiting for kidney transplantation, and chronic renal disease patients who has been transplanted 1-1½ year previously. The results will be compared to a gender- and age-matched healthy control group.
Status | Completed |
Enrollment | 93 |
Est. completion date | August 2015 |
Est. primary completion date | August 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients on a kidney transplant waiting list or patients who have had a kidney transplant (1-1½ year previously) - Dentate patients (>10 teeth) - Age >18 years - Danish language Exclusion Criteria: - Patients not capable of following the research protocol - Legally unavailable - Need of antibiotic prophylaxis with dental treatment - Heart valve surgery |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Denmark | Department of Odontology, Faculty of Health Sciences, University of Copenhagen | Copenhagen |
Lead Sponsor | Collaborator |
---|---|
University of Copenhagen | Danish Council for Independent Research - Medical Sciences, Rigshospitalet, Denmark, The Danish Dental Association |
Denmark,
Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008 Sep;3(5):1526-33. doi: 10.2215/CJN.00950208. Epub 2008 Aug 13. Review. — View Citation
McIntyre C, Harper I, Macdougall IC, Raine AE, Williams A, Baker LR. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients. Clin Nephrol. 1997 Dec;48(6):371-4. — View Citation
Thorman R. Oral health in patients with chronic kidney disease. Stockholm, Sweden: Karolinska Institutet; 2009
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Dental caries | Clinical registration of dental caries | Baseline examination (before oral care intervention), 3-months follow-up examination | No |
Primary | Gingival inflammation | Gingival inflammation measured by gingivitis index | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Primary | C-reactive protein, plasma | Blood sample | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Dental bacterial plaque | Measured by plaque index | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Periodontal disease | Measurement of attachment level | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Whole saliva flow rate, unstimulated | Sialometry | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Whole saliva flow rate, stimulated | Sialometry | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Saliva composition: Sodium | Sialochemistry | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Saliva composition: Chloride | Sialochemistry | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Saliva composition: Potassium | Sialochemistry | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Saliva composition: Total calcium | Sialochemistry | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Saliva composition: Inorganic phosphate | Sialochemistry | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Saliva composition: Total protein | Sialochemistry | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Saliva composition: Albumin | Sialochemistry | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Saliva composition: Amylase activity | Sialochemistry | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Saliva composition: Secretory IgA | Sialochemistry | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Oral candidiasis | Smear test | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Hematologic status: Erythrocytes | Blood sample | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Hematologic status: Hemoglobin | Blood sample | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Hematologic status: Leukocytes | Blood sample | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Hematologic status: Thrombocytes | Blood sample | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Hematologic status: Transferrin | Blood sample | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Hematologic status: Iron | Blood sample | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Calcium metabolism | Blood sample | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Phosphate metabolism | Blood sample | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Renal function: Carbamide | Blood sample | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Renal function: Bicarbonate | Blood sample | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Renal function: Creatinine | Blood sample | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Renal function: Albumin | Blood sample | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Renal function: Potassium | Blood sample | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Renal function: Sodium | Blood sample | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Oral Health Impact Profile | Quality of life questionnaire | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Secondary | Medical Outcomes Study Short Version | Quality of life questionnaire | Change from baseline examination (before oral care intervention) at 3-months follow-up examination | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT05056727 -
A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
|
Phase 3 | |
Withdrawn |
NCT01655186 -
A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus
|
Phase 2 | |
Completed |
NCT03481686 -
Therapeutic Education of Chronic Renal or Renal Transplant Patient in the Management of EPO Injections
|
N/A | |
Active, not recruiting |
NCT03672110 -
Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen
|
Phase 3 | |
Enrolling by invitation |
NCT02237534 -
Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia
|
Phase 4 | |
Completed |
NCT02126293 -
Correction of Zinc Deficiency in Children With Chronic Kidney Disease and Kidney Transplant
|
Phase 3 | |
Terminated |
NCT01533545 -
Effect of Epinephrine on Systemic Absorption of Mepivacaine in Uremic Patients
|
N/A | |
Completed |
NCT03280615 -
Omega 3 Fatty Acids in Patients With Chronic Renal Disease
|
Phase 3 | |
Completed |
NCT04498156 -
Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)
|
||
Recruiting |
NCT04020328 -
Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency
|
Phase 4 | |
Recruiting |
NCT06366529 -
Explore New Magnetic Resonance Technology in Assessment of Renal Dysfunction
|
||
Active, not recruiting |
NCT04876963 -
HOLT-ED: Holter-monitoring in End-stage Renal Disease
|
||
Completed |
NCT03836508 -
Effect of Dialysis Membranes on Inflammatory and Immune Processes in Hemodialysis
|
N/A | |
Completed |
NCT03250715 -
Effects of Low Level Laser Therapy on Functional Capacity and DNA Damage of Patients With Chronic Kidney Failure
|
N/A | |
Completed |
NCT03577249 -
Biological Effects of Citrate-buffered Solutions on Dialysis Efficiency and Systemic Inflammation
|
Phase 2/Phase 3 | |
Completed |
NCT01975818 -
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
|
Phase 2 | |
Active, not recruiting |
NCT05766644 -
App-based Education Program for CKD
|
N/A | |
Active, not recruiting |
NCT02791880 -
Acute Kidney Injury Genomics and Biomarkers in TAVR Study
|
||
Recruiting |
NCT02947750 -
Neurovascular Transduction During Exercise in Chronic Kidney Disease
|
Phase 2 | |
Terminated |
NCT02286258 -
Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)
|
Phase 1/Phase 2 |